Bloomios Selected as Exclusive Manufacturer for DRYWORLD’s New Athletic Performance CBD Product Line


Ryan Allway

March 31st, 2022

News, Top News


SANTA BARBARA, Calif.March 31, 2022 /PRNewswire/ — Bloomios, Inc. (OTCQB: BLMS), a leading manufacturer and wholesaler of hemp-derived cannabinoid nutraceuticals and cosmetics, has been selected as the exclusive cannabidiol (CBD) product manufacturer for DRYWORLD (OTC: IBGR), a maker of purpose-driven sports products designed to give athletes a performance edge.

 

DRYWORLD's CBD powdered drink crystals product line for hydration, recover and pre-workout.
DRYWORLD’s CBD powdered drink crystals product line for hydration, recover and pre-workout.

 

 

DRYWORLD engaged Bloomios to co-develop and produce the company’s branded, high-bioavailability CBD product line especially formulated for today’s athletes.

 

“We’ve partnered with Bloomios because of their extensive experience with CBD brand development and high-quality, high-volume manufacturing,” stated DRYWORLD president, Claudio Escobar. “Their vertical manufacturing process enabled us to rapidly create and launch this important addition to our portfolio of leading-edge athletic performance products.”

 

The initial lineup comprises seven products featuring hemp-derived CBD, including gel capsules, tinctures, powdered drinks, heat gels and pain-relief creams:

  • CBD Repair + Recovery Gel Capsule – 750 mg
  • CBD Tincture – 1500mg
  • CBD Complete Hydration powdered drink crystals – 150mg
  • CBD Complete Recovery powdered drink crystals – 375mg
  • CDB Complete Pre-Workout powdered drink crystal – 750mg
  • CBD Muscle Heat Gel – 3000mg
  • CBD Pain Relief Cream – 1000mg

 

 

The new DRYWORLD CBD products are based on all natural ingredients, premium CBD extracts, and are packed with vitamins, minerals, and herbs.

 

“Our exclusive partnership with DRYWORLD, an exciting premium fitness brand, represents our first entry into the fast-growing sports nutrition and performance market,” commented Bloomios CEO, Michael Hill. “This valuable engagement highlights our exceptional manufacturing process, premium packaging, and efficient in-house testing and sourcing solutions for brands looking to take advantage of today’s booming market for hemp-derived products.”

 

The products target a North American CBD market that is projected to grow at a 33% compounded annual growth rate (CAGR) to reach $61.3 billion by 2027.

 

The growing demand by athletes has been driven by the elimination of CBD restrictions and penalties for their use by major sports sanctioning bodies. There is also a growing body of science showing significant benefits of CBD for athletes, including the reduction of inflammation and aiding in recovery.

 

Barrett Evans, the president and a director of Bloomios also serves as CFO and director of DRYWORLD. While he was instrumental in bringing the companies together, he was not involved in the negotiations of the new relationship.

 

To purchase DRYWOLRD’s CBD products for athletes, go to Shop CBD Now!

 

About DRYWORLD
DRYWORLD is a premium performance sports brand offering innovative, superior quality apparel and gear for the athlete in all of us. Its build purpose-driven products give all athletes the edge. Engineered by athletes, proven by science. Keep up to date with DRYWORLD’s latest announcements by signing up for the company newsletter at thedryworld.com/contact.

 

To learn more, visit www.thedryworld.com

Connect with DRYWORLD: Website Shop Instagram Facebook Twitter

About Bloomios
Bloomios, Inc. researches, manufactures, markets and distributes U.S. hemp-derived cannabinoid supplements and cosmetic products through wholesale distribution channels and its wholly owned subsidiary, Bloomios Private Label. The company provides custom formulation, brand development, manufacturing and order fulfillment to a wide variety of customers, including small and major brands, chain stores, vape shops and distributors. It offers private- and white-label customers a collection of more than 80 customizable hemp products across 7 categories.

 

Bloomios is headquartered in Santa Barbara, California, with manufacturing and distribution in Daytona Beach, Florida.

 

To learn more, visit bloomios.com.

Important Cautions Regarding Forward-Looking Statements
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words “anticipate,” “believe,” “estimate,” “may,” “intend,” “expect” and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the sales of the company’s identity protection software products into various channels and market sectors, the issuance of the Company’s pending patent applications, COVID-19, and the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, the impact on the national and local economies resulting from terrorist actions, and U.S. actions subsequently; and other factors detailed in reports filed by the company.

 

Food and Drug Administration Disclosure
The product and formulation featured in this release is not for use by or sale to persons under the age of 12. This product should be used only as directed on the label. Consult with a physician before use if you have a serious medical condition or use prescription medications. A doctor’s advice should be sought before using this and any supplemental dietary product. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.

 

Dryworld Contact:
[email protected]

 

Investor Relations Contact:
Ronald Both or Justin Lumley
CMA Investor Relations
Tel (949) 432-7566
Email contact

 

Media Contact:
Tim Randall
CMA Media Relations
Tel (949) 432-7572
Email Contact

 

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.


Network Partners

Follow Us on Social Media

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading